Adiposogenital dystrophy cost-effectiveness of therapy: Difference between revisions
(Created page with "{{WH}} {{WS}} Category:Needs content Category:Disease Category:Endocrinology Category:Genetic disorders") |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Adiposogenital dystrophy}} | |||
{{CMG}} [[Ogechukwu Hannah Nnabude, MD]] | |||
==Overview== | |||
Treatment of [[adiposogenital dystrophy]] can very expensive, with hormone replacement and surgery costing tens of thousands of dollars per year. | |||
==Cost-effectiveness of therapy== | |||
The cost of treatment of adiposogenital dystrophy can be a financial strain. Hormone replacement can cost tens of thousands per year. For example, the cost of growth hormone replacement can be $20000 or more per year<ref name="pmid16520445">{{cite journal| author=Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR| title=Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature. | journal=Arch Pediatr Adolesc Med | year= 2006 | volume= 160 | issue= 3 | pages= 263-9 | pmid=16520445 | doi=10.1001/archpedi.160.3.263 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16520445 }} </ref>. Surgical treatment is also in the tens of thousands of dollars. Average cost of a full surgical day for intracranial tumor resection in the pediatric population was $15905 in 2014. This excluded cost for in-patient stay and other expenses<ref name="pmid25685648">{{cite journal| author=Stapleton AL, Tyler-Kabara EC, Gardner PA, Snyderman CH| title=The costs of skull base surgery in the pediatric population. | journal=J Neurol Surg B Skull Base | year= 2015 | volume= 76 | issue= 1 | pages= 39-42 | pmid=25685648 | doi=10.1055/s-0034-1390019 | pmc=4318741 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25685648 }} </ref>. | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 07:03, 29 December 2021
|
Adiposogenital dystrophy Microchapters |
|
Differentiating Adiposogenital dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adiposogenital dystrophy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Adiposogenital dystrophy cost-effectiveness of therapy |
|
FDA on Adiposogenital dystrophy cost-effectiveness of therapy |
|
CDC on Adiposogenital dystrophy cost-effectiveness of therapy |
|
Adiposogenital dystrophy cost-effectiveness of therapy in the news |
|
Blogs on Adiposogenital dystrophy cost-effectiveness of therapy |
|
Risk calculators and risk factors for Adiposogenital dystrophy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
Treatment of adiposogenital dystrophy can very expensive, with hormone replacement and surgery costing tens of thousands of dollars per year.
Cost-effectiveness of therapy
The cost of treatment of adiposogenital dystrophy can be a financial strain. Hormone replacement can cost tens of thousands per year. For example, the cost of growth hormone replacement can be $20000 or more per year[1]. Surgical treatment is also in the tens of thousands of dollars. Average cost of a full surgical day for intracranial tumor resection in the pediatric population was $15905 in 2014. This excluded cost for in-patient stay and other expenses[2].
References
- ↑ Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR (2006). "Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature". Arch Pediatr Adolesc Med. 160 (3): 263–9. doi:10.1001/archpedi.160.3.263. PMID 16520445.
- ↑ Stapleton AL, Tyler-Kabara EC, Gardner PA, Snyderman CH (2015). "The costs of skull base surgery in the pediatric population". J Neurol Surg B Skull Base. 76 (1): 39–42. doi:10.1055/s-0034-1390019. PMC 4318741. PMID 25685648.